NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes

NKG2D受体激活会加剧原发性移植物功能障碍的严重程度,并导致肺移植预后不良。

阅读:1
作者:Daniel R Calabrese ,Tasha Tsao ,Mélia Magnen ,Colin Valet ,Ying Gao ,Beñat Mallavia ,Jennifer J Tian ,Emily A Aminian ,Kristin M Wang ,Avishai Shemesh ,Elman B Punzalan ,Aartik Sarma ,Carolyn S Calfee ,Stephanie A Christenson ,Charles R Langelier ,Steven R Hays ,Jeffrey A Golden ,Lorriana E Leard ,Mary Ellen Kleinhenz ,Nicholas A Kolaitis ,Rupal Shah ,Aida Venado ,Lewis L Lanier ,John R Greenland ,David M Sayah ,Abbas Ardehali ,Jasleen Kukreja ,S Samuel Weigt ,John A Belperio ,Jonathan P Singer ,Mark R Looney

Abstract

Clinical outcomes after lung transplantation, a life-saving therapy for patients with end-stage lung diseases, are limited by primary graft dysfunction (PGD). PGD is an early form of acute lung injury with no specific pharmacologic therapies. Here, we present a large multicenter study of plasma and bronchoalveolar lavage (BAL) samples collected on the first posttransplant day, a critical time for investigations of immune pathways related to PGD. We demonstrated that ligands for NKG2D receptors were increased in the BAL from participants who developed severe PGD and were associated with increased time to extubation, prolonged intensive care unit length of stay, and poor peak lung function. Neutrophil extracellular traps (NETs) were increased in PGD and correlated with BAL TNF-α and IFN-γ cytokines. Mechanistically, we found that airway epithelial cell NKG2D ligands were increased following hypoxic challenge. NK cell killing of hypoxic airway epithelial cells was abrogated with NKG2D receptor blockade, and TNF-α and IFN-γ provoked neutrophils to release NETs in culture. These data support an aberrant NK cell/neutrophil axis in human PGD pathogenesis. Early measurement of stress ligands and blockade of the NKG2D receptor hold promise for risk stratification and management of PGD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。